Company: HCTI
Filing Date: 2025-11-17
Form Type: DEF 14A
Source: 0001213900-25-111526
Chunk: 4

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-17
Form: DEF 14A
Chunk 4
---
 28, 2025, and at any adjournment or postponement thereof. The Special Meeting will be held at 10:00 a.m. Pacific
Time at https://web.viewproxy.com/HCTI/2025SM.

On or about November 17, 2025, we will commence mailing of the proxy
materials which are also available at https://web.viewproxy.com/HCTI/2025SM.
The proxy materials are being sent to stockholders who owned our common stock at the close of business on November 12, 2025, the record
date for the special meeting (the “Record Date”). This Proxy Statement contains important information for you to consider
when deciding how to vote on the matters brought before the meeting. Please read it carefully.

Why am I receiving these materials?

| A. | We sent you this Proxy Statement because our Board is soliciting                                                                        
 your proxy to vote at the Special Meeting. This proxy statement summarizes the information you need to vote at the Special Meeting. You 
 do not need to attend the Special Meeting to vote your shares.                                                                          |

| Q. | What proposals will be voted on at the Special Meeting? |

| A. | Stockholders will vote on the following proposal at the Special 
 Meeting:                                                        |

| To consider and vote on a proposal to approve, for                                                                                
 purposes of Nasdaq Listing Rule 5635(d), issuances of the Company’s securities that are completed during the period from November 
 14, 2025 until February 28, 2025 that are in the aggregate up to $70 million (“Future Issuances”), as long as each Future         
 Issuance is within the Nasdaq Parameters (as defined herein) (the “Nasdaq Approval Proposal”).                                    |

| We will also consider other business, if any, that properly comes before the Special Meeting. |

| Q. | How does our Board recommend that stockholders vote on the 
 proposals?                                                 |

| A. | Our Board recommends that stockholders vote “FOR” 
 the Nasdaq Proposal.                              |

| Q. | Who is entitled to vote? |

| A. | The                                                                                                                                      
 record date for the Special Meeting is the close of business on November 12, 2025. As of the Record Date, there were 7,261,344 shares    
 of our common stock, par value $0.00001 per share, and 20,000 shares of the Series A Super Voting Preferred Stock, par value